Literature DB >> 9128853

delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.

T H Burkey1, R M Quock, P Consroe, W R Roeske, H I Yamamura.   

Abstract

We measured the ability of the cannabinoid agonists delta 9-tetrahydrocannabinol and R(+)-[2,3,-dihydro-5-methyl-3- [(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazin-yl]-(1-napht halenyl) methanone mesylate (WIN 55,212-2) to stimulate guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTP gamma S) binding in mouse brain membranes. delta 9-Tetrahydrocannabinol stimulated [35S]GTP gamma S binding by about 25% as compared to WIN 55,212-2. This is the first report demonstrating that delta 9-tetrahydrocannabinol acts as a partial agonist in stimulating [35S]GTP gamma S binding in the mouse brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128853     DOI: 10.1016/s0014-2999(97)00146-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?

Authors:  Stephen A Varvel; Laura E Wise; Aron H Lichtman
Journal:  Drug Dev Res       Date:  2009-12-01       Impact factor: 4.360

2.  Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

Authors:  Abir T El-Alfy; Kelly Ivey; Keisha Robinson; Safwat Ahmed; Mohamed Radwan; Desmond Slade; Ikhlas Khan; Mahmoud ElSohly; Samir Ross
Journal:  Pharmacol Biochem Behav       Date:  2010-03-21       Impact factor: 3.533

3.  Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats.

Authors:  Jonathan A Farrimond; Andrew J Hill; Benjamin J Whalley; Claire M Williams
Journal:  Psychopharmacology (Berl)       Date:  2010-03-27       Impact factor: 4.530

4.  Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497.

Authors:  Travis W Grim; Kimberly L Samano; Bogna Ignatowska-Jankowska; Qing Tao; Laura J Sim-Selly; Dana E Selley; Laura E Wise; Alphonse Poklis; Aron H Lichtman
Journal:  J Basic Clin Physiol Pharmacol       Date:  2016-05-01

5.  Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats.

Authors:  Mason M Silveira; Wendy K Adams; Maria Morena; Matthew N Hill; Catharine A Winstanley
Journal:  J Psychiatry Neurosci       Date:  2017-03       Impact factor: 6.186

6.  Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays.

Authors:  T W Grim; A J Morales; M M Gonek; J L Wiley; B F Thomas; G W Endres; L J Sim-Selley; D E Selley; S S Negus; A H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2016-08-17       Impact factor: 4.030

7.  An investigation into the structural determinants of cannabinoid receptor ligand efficacy.

Authors:  G Griffin; E J Wray; W K Rorrer; P J Crocker; W J Ryan; B Saha; R K Razdan; B R Martin; M E Abood
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

8.  Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- mice.

Authors:  Christopher S Breivogel; Jonathan M Lambert; Steven Gerfin; John W Huffman; Raj K Razdan
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

9.  Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.

Authors:  Brian D Kangas; Marcus S Delatte; V Kiran Vemuri; Ganesh A Thakur; Spyridon P Nikas; Kumara V Subramanian; Vidyanand G Shukla; Alexandros Makriyannis; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2013-01-03       Impact factor: 4.030

10.  Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Δ(9) -THC in cannabis users.

Authors:  Joshua A Lile; Thomas H Kelly; Richard J Charnigo; Audra L Stinchcomb; Lon R Hays
Journal:  J Clin Pharmacol       Date:  2013-06-10       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.